AstraZeneca launches Evinova to bring AI to clinical trials
Pharmaceutical giant AstraZeneca announced the launch of Evinova, a health technology business focused on bringing digital health solutions already in use globally by the pharma company to clinical research organizations (CROs), trial sponsors and care teams, and patients.
The new company will use established digital technology solutions to streamline clinical trial design and delivery in order to reduce time and costs in medicine development. The venture will also dive into digital remote patient monitoring and therapeutics.
The suite of digital solutions includes the Evinova unified trial solution, which enables direct collection of various data types, including digitally enabled endpoints and connected medical devices, at both trial sites and patients’ homes.
It also supports virtual visits, direct-to-patient medicine delivery, telehealth, remote monitoring and sample tracking.
Interaction occurs through a patient app, which is available in more than 40 countries and 80 languages.
A second offering is Evinova’s study design and planning module, which utilizes AI and machine learning to assist clinical teams in crafting optimal studies, considering essential design factors.
The tool enables teams to receive automated cost estimates and evaluate operational viability using real-time data at country and site levels. Additionally, the module offers historical data, forecasts future trends, estimates a study’s environmental impact and patient experience, and facilitates quicker decisions through collaborative scenario comparisons.
Evinova’s portfolio management tool provides reporting and governance with real-time insights and predictive algorithms. Researchers can use the platform to get a complete picture of the portfolio across all phases, and it allows for tracking clinical programs and trials at the global, regional, country and site level. It also helps study leaders understand deviations from plans.
Operating as a distinct entity within AstraZeneca, Evinova will also benefit from collaborations with CRO and biopharmaceutical company Parexel and fellow CRO Fortrea. These partnerships could help drive Evinova’s digital products to a broader customer base, which includes pharmaceutical, biotech and CROs in support of global clinical research initiatives.
Accenture and Amazon Web Services are also partnering to bolster the adoption and global reach of Evinova’s digital products.
“The future of medicine development can be accelerated with digital solutions. We believe Evinova’s combination of scientific expertise and track record in developing AI-enabled digital technologies at scale, provides a real opportunity to fundamentally improve patient care, drive healthcare transformation and reduce carbon emissions,” Pascal Soriot, CEO of AstraZeneca, said in a statement.
THE LARGER TREND
Deloitte’s recent analysis of the top 20 global pharmaceutical companies revealed a substantial decline in the projected return on investment for research and development, falling drastically to 1.2% in 2022 from 6.8% in 2021.
The findings indicated the critical need for an overhaul in drug development by leveraging digital technologies to enhance efficiency and improve clinical trials.
Scala Biodesign recently launched with $5.5 million in funding to develop bioproducts from proteins, having developed a computational solution using AI, modeling and data analysis of naturally occurring proteins to generate superior antibodies, enzymes and vaccine immunogens.
In August, AI-enabled clinical trial design company QuantHealth announced it had scored $15 million in a Series A funding round co-led by Pitango HealthTech and Bertelsmann Investments, bringing its total raise to $20 million.
Post Publications || Join us on Whatsapp || Post Disclaimer
SEND A STORY: Do you have a story for us or need a promotion/advertisement? Submit them via our email admin@edulearnweb or Ghanaeducation.org
TELEGRAM PAGE >>> [JOIN]
DOWNLOAD OUR EDUCATION NEWS APP - MOBILE APP
JOIN OUR EDUCATION NEW GROUPS (WHATSAPP)
Join one of our Whatsapp/Telegram Groups for current Ghana Education Service News Updates:
JOIN ONLY ONE... THANKS
TELEGRAM PAGE >>> [JOIN]
Group 1 >>New Group> [JOIN]
Group 2 >>New Group> [JOIN]
TELEGRAM PAGE >>> [JOIN]
Only websites that give us a URL backlink can repost our content on their sites.
The information contained in this post is for general information purposes only. The information is provided by edulearnweb.com and while we endeavour to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the post for any purpose.
||About Us|| Contact Us